EarningsQ3 2025 Earnings Report

BeOne Medicines (ONCN) Q3 2025 Earnings Report

0 Followers

MX:ONCN Q3 2025 EPS Results

Actual EPS$20.05

Consensus EPS$15.65

Beat/MissBeat by +$4.40

One Year Ago EPS-$21.15

Actual Revenue$26.01B

Expected Revenue$25.11B

Beat/MissBeat by +$900.81M

YoY Revenue Growth+40.04%

QuarterQ3 2025

Date11/06/2025

TimeBefore Open

Conference CallThursday, November 6, 2025

MX:ONCN Upcoming Earnings

BeOne Medicines's next earnings date is estimated for October 31, 2026, based on past reporting schedules.

MX:ONCN Q3 2025 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Oct 31, 2026	2026 (Q3)	34.69 / -	20.046	―
Aug 05, 2026	2026 (Q2)	30.55 / 37.70	16.736	125.27% (+20.97)
May 06, 2026	2026 (Q1)	17.80 / 36.05	0	―
Feb 26, 2026	2025 (Q4)	22.88 / 11.03	-26.299	141.96% (+37.33)
Nov 06, 2025	2025 (Q3)	15.65 / 20.05	-21.15	194.78% (+41.20)
Aug 06, 2025	2025 (Q2)	7.12 / 16.74	-21.15	179.13% (+37.89)
May 07, 2025	2025 (Q1)	-10.56 / 0.00	-44.323	―
Feb 27, 2025	2024 (Q4)	-18.61 / -26.30	-64.921	59.49% (+38.62)
Nov 12, 2024	2024 (Q3)	-20.49 / -21.15	36.966	-157.21% (-58.12)
Aug 26, 2024	2024 (Q2)	-40.26 / -21.15	-66.944	68.41% (+45.79)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed